Showing results (101-110 of 2,438) with videos related to
Sort By:
Pageof 244
Journal of the American Society for Mass Spectrometry|March 16, 2010
Shape changes induced by N-terminal platination of ubiquitin by cisplatinJonathan P Williams, Hazel I A Phillips, Iain Campuzano, et al.Cancer Letters|June 23, 2020
Featuring advanced translational strategies: Principles, techniques, devices and applicationsZhe LiuJournal of Medicinal Chemistry|December 17, 2009
Cytotoxicity, hydrophobicity, uptake, and distribution of osmium(II) anticancer complexes in ovarian cancer cellsSabine H van Rijt, Arindam Mukherjee, Ana M Pizarro, et al.Dalton Transactions (Cambridge, England : 2003)|February 27, 2018
Platinum(iv) azido complexes undergo copper-free click reactions with alkynesNicola J Farrer, Gitanjali Sharma, Rachel Sayers, et al.Inorganic Chemistry|August 20, 2002
Cadmium cyclam complexes: interconversion of cis and trans configurations and fixation of CO(2)Xiangyang Liang, John A Parkinson, Simon Parsons, et al.Journal of Biological Inorganic Chemistry : JBIC : a Publication of the Society of Biological Inorganic Chemistry|June 17, 2008
Sweetening ruthenium and osmium: organometallic arene complexes containing aspartameJennifer C Gray, Abraha Habtemariam, Marcel Winnig, et al.Metallomics : Integrated Biometal Science|February 9, 2025
On the origin of metal species in the human brain: a perspective on key physicochemical propertiesJake Brooks, James Everett, Peter J Sadler, et al.Molecular Pharmaceutics|April 13, 2011
Differences in the cellular response and signaling pathways between cisplatin and monodentate organometallic Ru(II) antitumor complexes containing a terphenyl ligandAnna Kisova, Lenka Zerzankova, Abraha Habtemariam, et al.Angewandte Chemie (International Ed. in English)|September 27, 2014
Platinum(II)-gadolinium(III) complexes as potential single-molecular theranostic agents for cancer treatmentZhenzhu Zhu, Xiaoyong Wang, Tuanjie Li, et al.Rapid Communications in Mass Spectrometry : RCM|October 22, 2009
Use of ion mobility mass spectrometry and a collision cross-section algorithm to study an organometallic ruthenium anticancer complex and its adducts with a DNA oligonucleotideJonathan P Williams, Julie Ann Lough, Iain Campuzano, et al.Pageof 244